Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-07-04
2006-07-04
Qian, Celine X. (Department: 1636)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000
Reexamination Certificate
active
07071323
ABSTRACT:
The DNA sequences of human and rat CRF2αreceptor promoters are disclosed. Certain functional fragments of the human CRF2αreceptor promoter are also disclosed. Further disclosed are a method of identifying functional fragments of human and rat CRF2αreceptor promoters and a method of identifying agents that can alter the activity of the human or rat CRF2αreceptor promoter.
REFERENCES:
patent: 5665543 (1997-09-01), Foulkes et al.
patent: 5776502 (1998-07-01), Foulkes et al.
patent: 5786203 (1998-07-01), Lovenberg et al.
patent: 5888811 (1999-03-01), Largent et al.
patent: 5965790 (1999-10-01), Acton
Homo Sapiens PAC clone RP5-1143H19. Gene Bank acession No. AC004976. First submitted by Waterson, R. H. by direct submission, Jun. 12, 1998.
Curt D. Sigmund, Viewpoint: Are Studies in Genetically Altered Mice Out of Control?, Arterioscler Thromb Vasc. Biol. 2000;20:1425-1429, 2000 American Heart Assoc., Inc.
Michelle Harvey, et al., Genetic background alters the spectrum of tumors that develop in p53-deficient mice, Jul. 1993, FASEB J. 7:938-943.
R. J. Wall, Transgenic Livestock: Progress and Prospects for the Future, 1996, Theriogenloogy 45:57-68, 1996.
“Researchers Discover DNA Sequence Controlling Obesity Gene,” Doctor's Guide to medical & Other News, 1999.
Bakshi VP and Kalin NH, “Corticotropin-Releasing Hormone and Animal Models of Anxiety: Gene-Environmental Interactions,” Soc. Biol. Psych. 48:1175-1198, 2000.
Bakshi VP, et al., “Reduction of stress-induced behavior by antagonism of corticotropin- releasing hormone 2 (CRH2) receptors in lateral septum of CRH1 receptors in amygdale.” J Neurosci 22:2926-2935, 2002.
Bale TL, et al., “Mice Deficient for Corticotropin-Releasing Hormone Receptor-2 Display Anxiety-Like Behaviour and are Hypersensitive to Stress,” Nat. Gene. 24:410-414, 2000.
Coste SC, et al., “Abnormal Adaptations to Stress and Impaired Cardiovascular Function in Mice Lacking Corticotropin-Releasing Hormone Receptor-2,” Nat. Gene. 24:403-409, 2000.
Eckart K, et al., “Actions of CRF and its analogs,” Curr. Med. Chem. 6(11):1035-53, 1999.
Eghbal-Ahmadi M, et al., “Differential Regulation of the Expression of Corticotropin-Releasing Factor Receptor type 2 (CFR2) in Hypothalamus and Amygdala of the Immature Rat by Sensory Input and Food Intake,” J. Neurosci. 19(10):3982-3991, 1999.
Grigoriadis DE, et al., “125I-Tyr0-Sauvagine: A Novel High Affinity Radioligand for the Pharmacological and Biochemical Study of Human Corticotropin-Releasing Factor2a Receptors,” Am. Soc. Pharmac. Exp. Therap. 50:679-686, 1996.
Grigoriadis DE, et al., “Characterization of Corticotropin-Releasing Factor Receptor Subtypes,” Ann. NY Acad. Sci. 780:60-80, 1996.
Kageyama K, et al., “Regulation of Corticotropin-Releasing Factor Receptor Type 2β Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines,” Endocrinology 141(7):2285-2293, 2000.
Kishimoto T, et al., “Deletion of Crhr2 Reveals an Anxiolytic Role for Corticotropin-Releasing Hormone Receptor-2,” Nat. Gene. 24:415-419, 2000.
Kostich WA, et al., “Molecular Identification and Analysis of a Novel Homan Corticotropin-Releasing Factor (CRF) Receptor: The CRF2? Receptor,” Molec. Endo. 12(8):1077-1085, 1998.
Liaw CW, et al., “Cloning and Characterization of the Human Corticotropin-Releasing Factor-2 Receptor Complementary Deoxyribonucleic Acid,” Endocrinology 13:72-77, 1996.
Lovenberg TW, et al., “Cloning and Characterization of a Functionally Distinct Corticotropin-Releasing Factor Receptor Subtype from Rat Brain,” Proc. Natl. Acad. Sci. USA 92:836-840, 1995.
Lovenberg TW, et al., “CRF2a and CRF2β Receptor mRNAs are Differentially Distributed Between the Rat Central Nervous system and Peripheral Tissues,” Endocrinology 136(9):4139-4142, 1995.
Makino S, et al., “Altered Expression of Type 2 CRH Receptor mRNA in the VMH by Glucocorticoids and Starvation,” Am. Physiol. Soc. R1138-R1145, 1998.
Owens MJ and Nemeroff CB, “Physiology and Pharmacology of Corticotropin-Releasing Factor,” Pharmac. Rev. 43(4):425-472, 1991.
Radulovic J, et al., “CRF and CRF Receptors,” Results and Problems in Cell Differentiation, 26:67-90, 1999.
Radulovic J, et al., “Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2,” J. Neurosci. 19(12):5016-5025, 1999.
Reul JM, Holsboer F “Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression,” Curr Opin Pharmacol 2:23-33, 2002.
Sakai K, et al., “The Genomic Organization of the Human Corticotropin-Releasing Factor Type-1 Receptor,” Gene 129:125-130, 1998.
Sánchez MM, et al., “Autoradiographic and In Situ Hybridization Localization of Corticotropin-Releasing Factor 1 and 2 Receptors in Nonhuman Primate Brain,” J. Compar. Neurol. 408:365-377, 1999.
Speiss J, et al., “Molecular Properties of the CRF Receptor,” TEM 9(4):140-145, 1998.
Steckler T and Holsboer F, “Corticotropin-Releasing Hormone Receptor Subtypes and Emotion,” Soc. Biol. Psych. 46:1480-1508, 1999.
Takahashi LK, et al., “Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety,” Brain Res 902:135-142, 2001.
Tsai-Morris CH, et al., “The Genomic Structure of the Rat Corticotropin Releasing Factor Receptor,” J. Biol. Chem. 271(24):14519-14525, 1996.
Zobel AW, et al., “Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated,” J Psychiatr Res 34:171-181, 2000.
Kalin Ned H.
Landry Charles F.
Nanda Steven A.
Roseboom Patrick H.
Qian Celine X.
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
LandOfFree
Promoter sequences for corticotropin releasing-factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promoter sequences for corticotropin releasing-factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promoter sequences for corticotropin releasing-factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3561435